The Peru Ministry of Health’s Directorate General of Medicines, Supplies, and Drugs (Digemid) has issued a critical alert concerning the seizure of counterfeit pharmaceutical products during national control and surveillance actions. This alert is directed at healthcare professionals, institutions, pharmaceutical and non-pharmaceutical establishments in both the public and private sectors, as well as the general public. The notification emphasizes the significant risks posed by counterfeit medications and urges heightened vigilance across all sectors involved in healthcare and pharmaceuticals.
During recent joint operations, various commercial establishments were found to be selling counterfeit pharmaceutical products. The operations were conducted with the participation of the JunÃn Regional Health Directorate (Diresa JunÃn), the First and Second Public Prosecutor’s Offices for Crime Prevention in Huancayo, the State Security Unit of the National Police, and the Provincial Municipality of Huancayo.
These coordinated efforts resulted in the seizure of multiple counterfeit products, revealing a troubling pattern of unauthorized sales. The following counterfeit products were seized; Sal de Andrews Effervescent Powder (5g sachet), Sal de Andrews Triple Action Effervescent Powder (7.9g sachet), Apronax 550mg Coated Tablet. These seizures highlight the pervasive issue of counterfeit pharmaceuticals infiltrating the market, posing severe risks to public health.
Risks and Recommendations
Due to the significant health risks posed by the distribution and consumption of these counterfeit products, it is crucial to verify the lot numbers of pharmaceutical products, medical devices, or sanitary products before purchase. Counterfeit drugs often contain incorrect ingredients, incorrect dosages, or may be contaminated with harmful substances.
The public is strongly advised against buying or using products suspected of being contaminated, altered, falsified, adulterated, or sold without proper sanitary registration. The use of counterfeit medications can lead to serious health consequences, including treatment failure, adverse reactions, and prolonged illness. The health authorities are keen to receive any information that can aid in the identification and seizure of counterfeit products, thereby preventing further distribution and use.
Continuous Efforts by Health Authorities
This alert highlights the continuous efforts by health authorities to ensure the safety and quality of products available in the market. By conducting regular surveillance and control operations, authorities aim to protect consumers from the dangers of counterfeit and unauthorized products. It is essential for everyone to stay informed and vigilant to avoid any adverse health effects resulting from the use of such products. The proactive measures taken by Digemid and other health authorities underscore their commitment to safeguarding public health.
Health professionals, consumers, and the general public must collaborate to identify and report counterfeit products. This collective effort is crucial in maintaining the integrity of the healthcare system and ensuring that only safe and effective medications are available to those who need them.
For more detailed information and updates, refer to the official notices issued by Digemid. Staying informed through official channels is the best way to ensure the use of safe, authorized pharmaceutical products. The health and safety of the population depend on the collective effort to combat the distribution and use of counterfeit pharmaceutical products. By remaining vigilant and reporting suspicious products, we can help protect our communities from the harmful effects of counterfeit medications.
Resource: Peru Ministry of Health’s Directorate General of Medicines Supplies and Drugs, July 17, 2024
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
